Peter Baumgarten

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Felix Sahm, Daniel Schrimpf, Damian Stichel et al. · The Lancet Oncology · 2017 · 814 citations · Full text

Chromatin, Mendelian Disorder, Dna Methylation-based Classification +12

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah et al. · Neuro-Oncology · 2019 · 255 citations · Full text

Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma

Alexander Scholz, Patrick N. Harter, Sebastian Cremer et al. · EMBO Molecular Medicine · 2015 · 167 citations · Full text

Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas

Pia S. Zeiner, Anna Golebiewska, Jenny Zinke et al. · Brain Pathology · 2018 · 155 citations · Full text

Immunology, Immunotherapeutics, High-grade Gliomas +23

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

Leah Katz, Thomas Hielscher, Benjamin Liechty et al. · Acta Neuropathologica · 2018 · 146 citations

Chromatin, Chromatin Structure, Medicine +7